InvestorsHub Logo
Followers 52
Posts 9070
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Monday, 12/18/2023 11:30:19 PM

Monday, December 18, 2023 11:30:19 PM

Post# of 13431
Though two other RSV vaccines exist on the commercial market, Moderna's would be the only one available in a prefilled syringe; this ease of use could give it the upper hand. If all goes well during the regulatory review, Moderna may become a two-product company in a matter of months,,,,,,,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News